Stifel Downgrades Biogen to Hold From Buy, Adjusts Price Target to $175 From $275

MT Newswires16minutes ago · Ratings

Palantir, MicroStrategy Could Be Added to Nasdaq 100 Friday. Moderna, Super Micro Could Be Dropped.

BarronsDec 14 00:46

Biogen Stock Touches 52-week Low at $153.55 Amid Challenges

InvestingDec 13 22:36

Biogen ALS Drug Needs to Be Covered by MA Plans, CMS Says

Seeking AlphaDec 13 06:37

Is Biogen Inc.'s (NASDAQ:BIIB) Stock Price Struggling As A Result Of Its Mixed Financials?

Yahoo FinanceDec 13 00:59

N-Lorem Foundation's Nano-rare Patient Colloquium Draws More Than 750 Attendees, Reinforcing Need for Treatment Options for People With Nano-rare Illnesses

BusinesswireDec 12 22:05